☆ 4.6 Letter

If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Related references

Note: Only part of the references are listed.
Letter Dermatology

Should biologics for psoriasis be interrupted in the era of COVID-19?

Mark Lebwohl et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Add to Collection
Article Dermatology

SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases

I. Colmenero et al.

BRITISH JOURNAL OF DERMATOLOGY (2020)

Add to Collection
Letter Dermatology

Skin is a potential host of SARS-CoV-2: A clinical, single-cell transcriptome-profiling and histologic study

Yangbai Sun et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Add to Collection
Review Dermatology

Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature

Igor Snast et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.